Colon Health Champion Program
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- Virginia Commonwealth University
- Study ID
- NCT07796334
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Intervention Arm: Colon Health Champions (CHC) Program — BEHAVIORALPeer-led interventions will discuss colorectal cancer (CRC) susceptibility and severity, and potential barriers to screening.
Study Details
This is a single arm-proof-of-concept trial. The primary goal of this trial is to assess the feasibility and acceptability of the Colon Health Champion Program
Key Dates
- First listed
- Sep 1, 2026
- Start date
- Sep 10, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 29 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Proof-of-concept trial to assess the Colon Health Champion ProgramParticipants will attend an in-person small group discussion. The discussion will teach participants about colon cancer and why it is important to get checked (screened).
Primary Outcome Measure
Determine feasibility of Colon Health Champions (CHC)-Successful Recruitment [ Time Frame: Day the last participant is enrolled, and the protocol closes to accrual, (estimated enrollment duration is up to 12 months) ]
Central Contacts
- Conney W. Berger, III, B.S.804-933-2913
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | Carrie A. Miller, Ph.D, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Richmond, VA
By condition
By specialty
By research site
Related Studies
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · La Jolla, California
- Colonoscopy vs Stool Testing for Older Adults With Colon PolypsRecruiting · Dartmouth-Hitchcock Medical Center · Tucson, Arizona
- A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid TumorsPHASE1 · Recruiting · Hefei TG ImmunoPharma Co., Ltd. · Dallas, Texas